Hughes Financial Services
AMPH icon

Hughes Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hughes Financial Services’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27 Hold
1
– – ﹤0.01% 1867
2026
Q2 		$20 Buy
+1
New +$20 ﹤0.01% 1755
2026
Q1 		– Sell
-24
Closed -$643 – 1722
2025
Q4 		$643 Hold
24
– – ﹤0.01% 866
2025
Q3 		$627 Buy
+24
New +$620 ﹤0.01% 854

Other funds holding AMPH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Hughes Financial Services's AMPH Position: Q3 2026 in Review

Hughes Financial Services held its Amphastar Pharmaceuticals (AMPH) position steady in Q3 2026 at 1 share worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Hughes Financial Services first reported a position in AMPH in Q3 2025 and has held it in 4 quarters since. The position peaked at $643 in Q4 2025. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Hughes Financial Services held 1 share of Amphastar Pharmaceuticals worth $27 as of Q3 2026.
  • Hughes Financial Services left its Amphastar Pharmaceuticals share count unchanged in Q3 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #1867 holding.
  • Hughes Financial Services first reported a position in Amphastar Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Hughes Financial Services's Amphastar Pharmaceuticals position peaked at $643 in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.